Biomaxima (WAR:BMX) Cyclically Adjusted FCF per Share: zł-0.25 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:BMX Biomaxima SA WAR:BMX
51 GF Score
Price zł9.91
GF Value zł15.28
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Biomaxima Cyclically Adjusted FCF per Share?

Biomaxima WAR:BMX 51 Cyclically Adjusted FCF per Share is zł-0.25 as of Mar. 2026. GuruFocus rates WAR:BMX with a GF Score™ of 51/100 and a GF Value™ of zł15.28 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Biomaxima's adjusted free cash flow per share for the three months ended in Mar. 2026 was zł-0.625. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is zł-0.25 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Biomaxima was 33.80% per year. The lowest was 33.80% per year. And the median was 33.80% per year.

As of today (2026-08-06), Biomaxima's current stock price is zł9.91. Biomaxima's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was zł-0.25. Biomaxima's Cyclically Adjusted Price-to-FCF of today is .

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Biomaxima was 228.00. The lowest was 42.46. And the median was 78.31.


Biomaxima  (WAR:BMX) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Biomaxima was 228.00. The lowest was 42.46. And the median was 78.31.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Biomaxima Cyclically Adjusted FCF per Share Related Terms


Biomaxima Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Biomaxima's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biomaxima Cyclically Adjusted FCF per Share Chart

Biomaxima Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.31 0.37 -0.01 -0.09 -0.15

Biomaxima Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.12 -0.14 -0.14 -0.15 -0.25

WAR:BMX vs TMO, DHR, IDXX: Cyclically Adjusted FCF per Share Comparison

For the Diagnostics & Research subindustry, Biomaxima's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomaxima Cyclically Adjusted Price-to-FCF vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biomaxima's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Biomaxima's Cyclically Adjusted Price-to-FCF falls into.


WAR:BMX
51GF Score
Biomaxima SA WAR:BMX
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biomaxima Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biomaxima's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.625/163.0700*163.0700
=-0.625

Current CPI (Mar. 2026) = 163.0700.

Biomaxima Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.099 99.552 -0.162
201609 -0.038 99.064 -0.063
201612 0.205 100.366 0.333
201703 -0.035 101.018 -0.056
201706 0.014 101.180 0.023
201709 -0.030 101.343 -0.048
201712 -0.038 102.564 -0.060
201803 -0.218 102.564 -0.347
201806 -1.071 103.378 -1.689
201809 -1.470 103.378 -2.319
201812 -1.407 103.785 -2.211
201903 0.195 104.274 0.305
201906 0.142 105.983 0.218
201909 0.220 105.983 0.339
201912 0.309 107.123 0.470
202003 0.422 109.076 0.631
202006 -0.900 109.402 -1.342
202009 0.942 109.320 1.405
202012 0.188 109.565 0.280
202103 0.927 112.658 1.342
202106 -0.324 113.960 -0.464
202109 -0.137 115.588 -0.193
202112 -1.521 119.088 -2.083
202203 6.265 125.031 8.171
202206 1.907 131.705 2.361
202209 -0.839 135.531 -1.009
202212 -1.218 139.113 -1.428
202303 -1.252 145.950 -1.399
202306 -1.492 147.009 -1.655
202309 -0.236 146.113 -0.263
202312 -0.843 147.741 -0.930
202403 -0.034 149.044 -0.037
202406 -0.081 150.997 -0.087
202409 -0.620 153.439 -0.659
202412 0.155 154.660 0.163
202503 -0.167 157.021 -0.173
202506 -0.102 157.509 -0.106
202509 0.162 158.000 0.167
202512 0.667 158.320 0.687
202603 -0.625 163.070 -0.625

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of zł-0.25 mean?
Biomaxima (WAR:BMX) has a Cyclically Adjusted FCF per Share of zł-0.25 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Biomaxima and its competitors.
Is Biomaxima's Cyclically Adjusted FCF per Share too high?
Biomaxima's current Cyclically Adjusted FCF per Share is zł-0.25. Overall, Biomaxima has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Biomaxima's Cyclically Adjusted FCF per Share compare to TMO and DHR?
Biomaxima's Cyclically Adjusted FCF per Share of zł-0.25 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted FCF per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Biomaxima and its competitors. Biomaxima's current Cyclically Adjusted FCF per Share is zł-0.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biomaxima stock overvalued right now?
Based on GuruFocus' analysis, Biomaxima (WAR:BMX) is currently considered Possible Value Trap. The stock's GF Value™ is zł15.28, compared to a current price of zł9.91 — trading 35.1% below its estimated fair value. The current Cyclically Adjusted FCF per Share is zł-0.25. Biomaxima's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Biomaxima (WAR:BMX), the current Cyclically Adjusted FCF per Share is zł-0.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biomaxima (WAR:BMX) Overvalued in 2026?

Based on GuruFocus' analysis, Biomaxima stock appears to be undervalued. The current stock price of zł9.91 is trading 35.1% below its estimated GF Value™ of zł15.28. GuruFocus considers Biomaxima to be Possible Value Trap.

Key valuation signals for WAR:BMX:

  • Cyclically Adjusted FCF per Share: zł-0.25
  • GF Value™: zł15.28 vs. price of zł9.91 (35.1% below fair value)
  • GF Score™: 51/100 with 4 warning signs

No single metric tells the full story. See the WAR:BMX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biomaxima Business Description

Address 5 Vetterow Street, Lublin, POL, 20-277
BioMaxima SA is a Polish company operating in the market of laboratory diagnostics. It is a manufacturer of microbiological substrates as well as a wide range of reagents and diagnostic equipment. The company is also a distributor of products of recognized multinational diagnostic companies such as: Accelerate Diagnostics, Nova Biomedical, PHC Group, Technoclone, Kabe and Biolog.
51GF Score

Get the complete analysis for WAR:BMX

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł9.91
Price
zł15.28
GF Value